Novel tetrahydropyrido[3,2-c]pyrroles as 5-HT7 antagonists

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 1, 2011, Pages 42-44

  Rudolph, Dale A ^a   Dvorak, Curt A ^a   Dvorak, Lisa ^a   Nepomuceno, Diane ^a   Bonaventure, Pascal ^a   Lovenberg, Timothy W ^a   Carruthers, Nicholas I ^a  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

5 HT7; 5 HT7 receptor; Serotonin

Indexed keywords

PYRROLE DERIVATIVE; SEROTONIN 7 RECEPTOR; SEROTONIN 7 RECEPTOR ANTAGONIST; SEROTONIN RECEPTOR AFFECTING AGENT; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; PROTEIN BINDING; PYRROLES; RATS; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 78650514174     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.11.078     Document Type: Article

References (20)

1. P.B. Hedlund, and J.G. Sutcliffe Trends Pharmacol. Sci. 25 2004 481
2. J.A. Bard, J. Zgombic, N. Adham, P. Vaysse, T.A. Branchek, and R.L. Weinshank J. Biol. Chem. 268 1993 23422
3. B.R. Tuladhar, L. Ge, and R.J. Naylor Br. J. Pharmacol. 138 2003 1210
4. D.R. Thomas, P.J. Atkinson, P.G. Hastie, J.C. Roberts, D.N. Middlemiss, and G.W. Price Neuropharmacology 42 2002 74
5. Z.P. To, D.W. Bonhaus, R.M. Eglen, and L.B. Jakeman Br. J. Pharmacol. 115 1995 107
6. K. Varnas, D.R. Thomas, E. Tupala, J. Tiihonen, and H. Hall Neurosci. Lett. 367 2004 313
7. T.W. Lovenberg, B.M. Baron, L. de Lecea, J.D. Miller, R.A. Prosser, M.A. Rea, P.E. Foye, M. Racke, A.L. Slone, B.W. Siegel, P.E. Danielson, J.G. Sutcliffe, and M.G. Erlander Neuron 11 1993 449
8. P.B. Hedlund, P.E. Danielson, E.A. Thomas, K. Slanina, M.J. Carson, and J.G. Sutcliffe Proc. Natl. Acad. Sci. 100 2003 1375
9. M. Hery, A.M. Franzois-Bellan, F. Hery, P. Deprez, and D. Becquet Endocrine 7 1997 261
10. P.J. Lovell, S.M. Bromidge, S. Dabbs, D.M. Duckworth, I.T. Forbes, A.J. Jennings, F.D. King, D.N. Middlemiss, S.K. Rahman, D.V. Saunder, L.L. Collin, J.J. Hagan, G.J. Riley, and D.R. Thomans J. Med. Chem. 43 2000 342
11. P.B. Hedlund, S. Huitron-Resendiz, S.J. Henriksen, and J.G. Sutcliffe Biol. Psychiatry 58 2005 831
12. A. Wesolowska, A. Nikiforuk, K. Stachowicz, and E. Tatarczynska Neuropharmacology 51 2006 578
13. Winters, G.; Sala, A.; Barone, D. EP 86422A2, 1983.
14. S. Lim, I. Jabin, and G. Revial Tetrahedron Lett. 40 1999 4177
15. 2O to afford the desired compounds 6 as their HCl salts.
16. C.B. Gairaud, and G.R. Lappin J. Org. Chem. 18 1953 1
17. i. Experiments were conducted in triplicate. Stock drug solutions (10 mM) were prepared in DMSO (the final assay concentration of DMSO not exceeding 0.4%). Drug dilutions were prepared in assay buffer.
18. J.G. Topliss J. Org. Chem. 15 1972 1006
19. 50.
20. J.J. Hagan, G.W. Price, P. Jeffrey, N.J. Deeks, T. Stean, D. Piper, M.I. Smith, N. Upton, A.D. Medhurst, D. Middlemiss, G.J. Riley, P.J. Lovell, S.M. Bromidge, and D.R. Thomas Br. J. Pharmacol. 130 2000 539